Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study

PURPOSE: Current TNM staging does not appropriately identify high-risk colorectal cancer (CRC) patients. The aim of this study was to evaluate whether the presence of disseminated tumor cells (DTCs) in the bone marrow (BM) and the presence of stroma in the primary tumor, i.e., the tumor-stroma ratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelaar, F. J., van Pelt, G. W., van Leeuwen, A. M., Willems, J. M., Tollenaar, R. A. E. M., Liefers, G. J., Mesker, W. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121180/
https://www.ncbi.nlm.nih.gov/pubmed/27613548
http://dx.doi.org/10.1007/s13402-016-0296-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121180/
https://www.ncbi.nlm.nih.gov/pubmed/27613548
http://dx.doi.org/10.1007/s13402-016-0296-2

Ejemplares similares